Former Rep. Adam Kinzinger (R-Ill.) on Tuesday slammed President Trump over the first 100 days of his second term, calling them a “failure.” “With the 100th day of the Trump presidency here, it’s the ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012.

KANSAS CITY, Mo. — Minutes after their first loss this season, the Chiefs’ mood inside the visitors’ locker room at Highmark Stadium was split. On one side of the room was the offense, a quiet group.

The IRS's First-Time Abatement program is a key penalty relief tool for taxpayers with a clean compliance history. For tax professionals, it offers the most direct way to resolve failure-to-file, ...

The combination of sacubitril and valsartan appeared superior to enalapril in the first randomized trial to generate high-quality evidence to support a drug treatment specifically for patients with ...

The group earned a reputation as "your favorite band’s favorite band" before flaming out, only to be reborn with a new perspective on life and the music business. By Brian Davids Writer It’s rare for ...

In a matter of months, over $4 trillion dollars in tax hikes are set to kick in unless Republicans can get their act together on budget reconciliation. As White House director of Legislative Affairs ...

Adding ianalumab to standard-of-care second-line eltrombopag prolonged the time to treatment failure vs placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) in the pivotal ...

Courtney is a writer for Collider. She graduated from William Paterson University with a Bachelor's Degree in English Writing. During her time there, Courtney joined an Honors Writing Fraternity. Ever ...

Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...

Jan 19 (Reuters) - Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable tablet, as the first drug to delay congestive heart ...